1. Home
  2. VNDA vs IPI Comparison

VNDA vs IPI Comparison

Compare VNDA & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNDA
  • IPI
  • Stock Information
  • Founded
  • VNDA N/A
  • IPI 2000
  • Country
  • VNDA United States
  • IPI United States
  • Employees
  • VNDA N/A
  • IPI N/A
  • Industry
  • VNDA Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • VNDA Health Care
  • IPI Industrials
  • Exchange
  • VNDA Nasdaq
  • IPI Nasdaq
  • Market Cap
  • VNDA 362.6M
  • IPI 309.4M
  • IPO Year
  • VNDA 2006
  • IPI 2008
  • Fundamental
  • Price
  • VNDA $6.30
  • IPI $26.14
  • Analyst Decision
  • VNDA Buy
  • IPI Hold
  • Analyst Count
  • VNDA 1
  • IPI 1
  • Target Price
  • VNDA $11.00
  • IPI $23.00
  • AVG Volume (30 Days)
  • VNDA 836.8K
  • IPI 72.7K
  • Earning Date
  • VNDA 07-29-2024
  • IPI 08-05-2024
  • Dividend Yield
  • VNDA N/A
  • IPI N/A
  • EPS Growth
  • VNDA N/A
  • IPI N/A
  • EPS
  • VNDA N/A
  • IPI N/A
  • Revenue
  • VNDA $177,604,000.00
  • IPI $271,450,000.00
  • Revenue This Year
  • VNDA $2.98
  • IPI N/A
  • Revenue Next Year
  • VNDA $19.49
  • IPI $4.92
  • P/E Ratio
  • VNDA N/A
  • IPI N/A
  • Revenue Growth
  • VNDA N/A
  • IPI N/A
  • 52 Week Low
  • VNDA $3.30
  • IPI $17.52
  • 52 Week High
  • VNDA $6.75
  • IPI $28.30
  • Technical
  • Relative Strength Index (RSI)
  • VNDA 61.57
  • IPI 62.53
  • Support Level
  • VNDA $5.89
  • IPI $24.07
  • Resistance Level
  • VNDA $6.37
  • IPI $26.39
  • Average True Range (ATR)
  • VNDA 0.24
  • IPI 0.84
  • MACD
  • VNDA 0.06
  • IPI 0.25
  • Stochastic Oscillator
  • VNDA 94.35
  • IPI 93.80

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: